Covid-19: Painkiller Ibuprofen tested as potential treatment in London
Half of the 230 COVID-19 patients participating in the trial were given a special formulation of Ibuprofen, distinct from the over-the-counter variant sold across the world.
Suscribirse a:
Enviar comentarios (Atom)
No hay comentarios:
Publicar un comentario